Efficacy of antibodies to adhesion molecules, CDlla or CD18, in rabbit models of uveitis

James (Jim) Rosenbaum, Richard S. Boney

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Adhesion molecules play a critical role in leukocyte emigration to a site of inflammation. In order to assess the potential therapeutic benefit of blocking adhesion molecule function in anterior uveitis, the efficacy of antibodies to specific adhesion molecules was tested in 3 separate rabbit models of anterior uveitis. Antibodies to two different leukocyte molecules, CDlla and CD18, and antibodies to the endothelial ligand for CD11a/CD18, ICAM-1 (intercellular adhesion molecule-1, CD54), were studied in inflammation after intravitreally injected interleukin-1, intravitreally injected endotoxin, or an ocular reversed passive Arthus reaction. The CD18 antibody (2 mg/kg intravenously) reduced the cellular infiltrate with each of these 3 models. The antibody to CDlla was equally effective but was tested only in the IL-1-induced model. The antibody to ICAM-1 reduced the cellular infiltrate associated with this model, but the results did not reach statistical significance. None of the antibodies was able to reduce the associated increase in vascular permeability as measured by protein in the aqueous humor. The antibody to CD18 failed to reduce the inflammation if it was administered 24 hours after the intravitreally injected endotoxin. These observations demonstrate that leukocyte migration into the anterior segment of the eye is dependent on the CD11a/CD18 complex.

Original languageEnglish (US)
Pages (from-to)827-831
Number of pages5
JournalCurrent Eye Research
Volume12
Issue number9
DOIs
StatePublished - 1993

Fingerprint

Uveitis
Rabbits
Antibodies
Anterior Uveitis
Leukocytes
Intercellular Adhesion Molecule-1
Inflammation
Interleukin-1
Endotoxins
Arthus Reaction
Anterior Eye Segment
Aqueous Humor
Emigration and Immigration
Capillary Permeability
Ligands

ASJC Scopus subject areas

  • Ophthalmology
  • Sensory Systems
  • Cellular and Molecular Neuroscience

Cite this

Efficacy of antibodies to adhesion molecules, CDlla or CD18, in rabbit models of uveitis. / Rosenbaum, James (Jim); Boney, Richard S.

In: Current Eye Research, Vol. 12, No. 9, 1993, p. 827-831.

Research output: Contribution to journalArticle

@article{af7361ffd399451ab10c54d7377aeb39,
title = "Efficacy of antibodies to adhesion molecules, CDlla or CD18, in rabbit models of uveitis",
abstract = "Adhesion molecules play a critical role in leukocyte emigration to a site of inflammation. In order to assess the potential therapeutic benefit of blocking adhesion molecule function in anterior uveitis, the efficacy of antibodies to specific adhesion molecules was tested in 3 separate rabbit models of anterior uveitis. Antibodies to two different leukocyte molecules, CDlla and CD18, and antibodies to the endothelial ligand for CD11a/CD18, ICAM-1 (intercellular adhesion molecule-1, CD54), were studied in inflammation after intravitreally injected interleukin-1, intravitreally injected endotoxin, or an ocular reversed passive Arthus reaction. The CD18 antibody (2 mg/kg intravenously) reduced the cellular infiltrate with each of these 3 models. The antibody to CDlla was equally effective but was tested only in the IL-1-induced model. The antibody to ICAM-1 reduced the cellular infiltrate associated with this model, but the results did not reach statistical significance. None of the antibodies was able to reduce the associated increase in vascular permeability as measured by protein in the aqueous humor. The antibody to CD18 failed to reduce the inflammation if it was administered 24 hours after the intravitreally injected endotoxin. These observations demonstrate that leukocyte migration into the anterior segment of the eye is dependent on the CD11a/CD18 complex.",
author = "Rosenbaum, {James (Jim)} and Boney, {Richard S.}",
year = "1993",
doi = "10.3109/02713689309020387",
language = "English (US)",
volume = "12",
pages = "827--831",
journal = "Current Eye Research",
issn = "0271-3683",
publisher = "Informa Healthcare",
number = "9",

}

TY - JOUR

T1 - Efficacy of antibodies to adhesion molecules, CDlla or CD18, in rabbit models of uveitis

AU - Rosenbaum, James (Jim)

AU - Boney, Richard S.

PY - 1993

Y1 - 1993

N2 - Adhesion molecules play a critical role in leukocyte emigration to a site of inflammation. In order to assess the potential therapeutic benefit of blocking adhesion molecule function in anterior uveitis, the efficacy of antibodies to specific adhesion molecules was tested in 3 separate rabbit models of anterior uveitis. Antibodies to two different leukocyte molecules, CDlla and CD18, and antibodies to the endothelial ligand for CD11a/CD18, ICAM-1 (intercellular adhesion molecule-1, CD54), were studied in inflammation after intravitreally injected interleukin-1, intravitreally injected endotoxin, or an ocular reversed passive Arthus reaction. The CD18 antibody (2 mg/kg intravenously) reduced the cellular infiltrate with each of these 3 models. The antibody to CDlla was equally effective but was tested only in the IL-1-induced model. The antibody to ICAM-1 reduced the cellular infiltrate associated with this model, but the results did not reach statistical significance. None of the antibodies was able to reduce the associated increase in vascular permeability as measured by protein in the aqueous humor. The antibody to CD18 failed to reduce the inflammation if it was administered 24 hours after the intravitreally injected endotoxin. These observations demonstrate that leukocyte migration into the anterior segment of the eye is dependent on the CD11a/CD18 complex.

AB - Adhesion molecules play a critical role in leukocyte emigration to a site of inflammation. In order to assess the potential therapeutic benefit of blocking adhesion molecule function in anterior uveitis, the efficacy of antibodies to specific adhesion molecules was tested in 3 separate rabbit models of anterior uveitis. Antibodies to two different leukocyte molecules, CDlla and CD18, and antibodies to the endothelial ligand for CD11a/CD18, ICAM-1 (intercellular adhesion molecule-1, CD54), were studied in inflammation after intravitreally injected interleukin-1, intravitreally injected endotoxin, or an ocular reversed passive Arthus reaction. The CD18 antibody (2 mg/kg intravenously) reduced the cellular infiltrate with each of these 3 models. The antibody to CDlla was equally effective but was tested only in the IL-1-induced model. The antibody to ICAM-1 reduced the cellular infiltrate associated with this model, but the results did not reach statistical significance. None of the antibodies was able to reduce the associated increase in vascular permeability as measured by protein in the aqueous humor. The antibody to CD18 failed to reduce the inflammation if it was administered 24 hours after the intravitreally injected endotoxin. These observations demonstrate that leukocyte migration into the anterior segment of the eye is dependent on the CD11a/CD18 complex.

UR - http://www.scopus.com/inward/record.url?scp=0027492967&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027492967&partnerID=8YFLogxK

U2 - 10.3109/02713689309020387

DO - 10.3109/02713689309020387

M3 - Article

C2 - 7903235

AN - SCOPUS:0027492967

VL - 12

SP - 827

EP - 831

JO - Current Eye Research

JF - Current Eye Research

SN - 0271-3683

IS - 9

ER -